The center becomes the first in the country to administer a commercial gene therapy infusion to treat Hemophilia A, the common disorder affecting males.
CHOC-led study reveals racial disparities in fatal encounters between youth and law enforcement
CHOC “lets the data speak for itself” in first-of-its-kind study into pediatric injuries sustained during law enforcement encounters.
Evaluating newer medications in the treatment of neonatal seizures; predicting future epilepsy risk after neonatal seizures
CHOC aims to improve care of neonatal seizures through research into medications with fewer side effects than traditional anti-epileptics.
AI-powered modeling, custom implants improve scoliosis surgery outcomes
CHOC uses innovative artificial intelligence (AI) tools to restore sagittal alignment using patient-specific rods to treat scoliosis.
CHOC leads the way in innovative uses of augmented and virtual reality to support patient and family experiences
CHOC’s innovative augmented and virtual reality tools support positive patient outcomes by encouraging ambulation, education and more.
CHOC data scientists win best paper award from peer-reviewed journal
Associates in the CHOC Research Computational and Data Science Program have won a prestigious award from Data in Brief, a national journal.
